Food & Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food & Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angina
Study shows no benefit from early PCI/CABG in high-risk unstable angina patients
September 24th, 2004
Patients with chest pain are recognized as being at high risk of subsequent adverse cardiac events when their plasma levels of cardiac troponin are elevated as evidence of myocardial damage. Based on earlier studies, various guidelines recommend early angiography and PCI or CABG (early invasive strategy) in all these high-risk patients. Dutch clinical investigators presented data during the European Society of Cardiology Congress in Munich showing that modern medical treatment, and angiography followed by PCI or CABG in selected patients (selective invasive strategy), may be equally effective. Patients were eligible when presenting with chest pain...
Source: Food & Drug Law Weekly (2004-09-24)
|
